印度太阳药业发展经验及其对我国药企发展的借鉴  

Development experience of India Sun Pharma Industries and its inspiration to China

作　　者：陈文静[1] 臧运森 汤少梁[1] 

机构地区：[1]南京中医药大学,南京210023

出　　处：《中国新药杂志》2017年第4期375-379,共5页Chinese Journal of New Drugs

基　　金：2015年教育部人文社科规划基金项目(15YJA630060);江苏省社科基金项目(15GLB014)

摘　　要：与中国药品生产企业相比,无论是在资金支持上,还是在企业发展的科研能力上,印度制药企业都存在诸多不足,但印度制药企业却开拓了医药企业新的发展模式,印度太阳药业已经成为世界知名的制药企业。我国制药企业与太阳制药的发展环境和起点比较接近,通过对太阳药业的发展历史梳理和经验总结,探讨适合我国药企发展的思路,为我国制药企业的发展提供一定的借鉴参考。Compared with the Chinese pharmaceutical production enterprises,whether in the financial support,or in the scientific research ability of the enterprise development,India pharmaceutical enterprises have many shortcomings,but India pharmaceutical companies have opened up a new development model of pharmaceutical companies. The India Sun Pharma Industries has become one of the world＇s leading pharmaceutical companies. The development environment and starting point of pharmaceutical enterprises in China are close to India. In this article,we summarized several trains of thought suitable for China＇s pharmaceutical development by carding the development history and experience of the India Sun Pharma Industries,in order to provide some references for the development of pharmaceutical enterprises in China.

关 键 词：印度 太阳药业 创新 发展经验 

分 类 号：R95[医药卫生—药学]